5-(2,6-Difluorophenyl)-1,3,4-thiadiazol-2-amine, 95%, 2.5g

4-chloro-3-{5-[(E)-2-nitrovinyl]-2-furyl}benzoic acid, 95.0%, 5g

Methyl 2-oxo-2-phenylacetate, 99.00%, 1g

2-Methyl-4-(morpholin-4-yl)butan-2-amine dihydrochloride, 95.0%, 100mg

3-Bromo-2,4-dimethyl-5-phenylthiophene>98.0%(GC)5g

1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13-tetraoxa-4-azapentadecan-15-oic acid, 95%, 250mg

Asta in molibdeno 99,95% 5,0 mm diametro 100 mm

3-Bromo-2,4,6-trimethylnitrobenzene, 95.0%, 250mg

1-Phenyl-2,5,8,11-tetraoxatridecan-13-ol, 98.0%, 5g

Acido tartarico DL, minimo 99,5%, anidro, 25 g, confezione in plastica.

1-Butanol, 2-[[9-(1-methylethyl)-6-[[[4-(2-pyridinyl)phenyl]methyl]amino]-9H-purin-2-yl]amino]-, (2R)-, 99%, 50mg

4-Amino-6-iodopyrimidine, 95.0%, 5g

tert-Butyl 2,6-diazaspiro[3.4]octane-2-carboxylate, 95.0%, 25g